ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | -58.3% | 1,700 | -43.3% | 0.00% | -50.0% |
| Q1 2015 | $12,000 | -64.7% | 3,000 | -40.0% | 0.00% | -60.0% |
| Q4 2014 | $34,000 | -93.3% | 5,000 | -89.9% | 0.01% | -92.5% |
| Q2 2014 | $507,000 | +39.3% | 49,510 | +63.4% | 0.07% | +36.7% |
| Q1 2014 | $364,000 | +538.6% | 30,300 | +506.0% | 0.05% | +390.0% |
| Q4 2013 | $57,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |